Voice Disorders: Clinical Trials

5 trials for Voice Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 completed. 5 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 15Recruiting 3, Completed 2

Follow Voice Disorders: new trials by email Literature Review of Voice Disorders trials Research Report on Voice Disorders

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Intralesional Injection of Corticosteroids Combined with Hyaluronidase in Treatment of Minimal Associated Pathological Lesions of Vocal Folds, Participants and Condition: Patients with Benign Vocal Fold Lesions, Intervention: Intralesional Injection Via Working Channel of Nasofiberscope
Intralesional injection of steroids (betamethasone), (Betafos®) and hyaluronidase (enzyme), (Hynidase®) into benign vocal fold lesions by a naso-fiberscope with a side working channel(Storz 11001UD1) - Voice and Voice Disorders
Early Phase 1RecruitingMansoura University202026-01-012025-03-03
Project 4: Ambulatory Biofeedback and Voice Therapy for Patients With Vocal Hyperfunction
Ambulatory Voice Monitoring with Biofeedback (AVM-B), Conversation Training Therapy - Voice Disorders, Vocal Fold Polyp
Early Phase 1RecruitingMassachusetts General Hospital1002024-03-012026-09-08
Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor
Brain imaging, Laryngeal sensory block with topical bupivacaine - Laryngeal Dystonia, Spasmodic Dysphonia
Early Phase 1RecruitingMassachusetts Eye and Ear Infirmary1652022-03-242025-12-02
Comprehensive Voice Rehabilitation Program Compared With Vocal Function Exercises
Voice therapy - Dysphonia
Early Phase 1CompletedFederal University of São Paulo1062011-01-012015-04-07
Interaction of Caffeine and Hydration on Voice
C2 (200mg of caffeine; 1/2 L of water), C3(200mg of caffeine; 1 L of water), C1 (200mg of caffeine, no water) - Voice Disorders
Early Phase 1CompletedSouthern Illinois University Carbondale802010-10-012013-06-11

Narrower conditions

Dysphonia (2)  ·  Hoarseness (1)  ·  Tremor (1)

Broader conditions

Laryngeal Diseases (5)  ·  Nervous System Diseases (5)  ·  Neurologic Manifestations (5)  ·  Otorhinolaryngologic Diseases (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Respiratory Tract Diseases (5)  ·  Signs and Symptoms (5)  ·  Dyskinesias (1)  ·  Respiration Disorders (1)  ·  Signs and Symptoms, Respiratory (1)

Interventions

Betamethasone (1)  ·  Biofeedback, Psychology (1)  ·  Bupivacaine (1)  ·  Caffeine (1)  ·  Enzymes (1)  ·  Hyaluronoglucosaminidase (1)  ·  Neuroimaging (1)  ·  Water (1)

Sponsors

Federal University of São Paulo (1)  ·  Mansoura University (1)  ·  Massachusetts Eye and Ear Infirmary (1)  ·  Massachusetts General Hospital (1)  ·  Southern Illinois University Carbondale (1)

Countries

United States (3)  ·  Egypt (1)

Top investigators

Kristina Simonyan, MD, PhD (1)  ·  Maria Claudia Franca, Ph.D. (1)  ·  Robert Hillman, PhD, CCC-SLP (1)  ·  Vanessa P Vieira, PhD (1)

Results publications

PMID 11566828, PMID 18334848

NIH funding

P50DC015446 (1)